Trials / Conditions / Primary Sclerosing Cholangitis (PSC)

Primary Sclerosing Cholangitis (PSC)

19 registered clinical trials studyying Primary Sclerosing Cholangitis (PSC) — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplanta NCT07477782	Assistance Publique - Hôpitaux de Paris	Phase 2
Not Yet Recruiting	Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis NCT07341282	McMaster University	Phase 2
Recruiting	A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC NCT06699121	LISCure Biosciences	Phase 2
Not Yet Recruiting	Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis NCT06975150	CuromeBiosciences	Phase 2
Active Not Recruiting	S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC) NCT06026865	Medical University of Warsaw	N/A
Completed	Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0 NCT05082779	Cascade Pharmaceuticals, Inc	Phase 1
Completed	Endoscopy and Primary Sclerosing Cholangitis NCT06686810	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Completed	Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechani NCT06037577	ChemomAb Ltd.	Phase 1
Completed	Cholangioscopy in Primary Sclerosing Cholangitis (PSC) NCT03766035	Boston Scientific Corporation	—
Completed	A POC and Dose-Ranging Study of HTD1801 in PSC Patients NCT03333928	HighTide Biopharma Pty Ltd	Phase 2
Recruiting	Swiss Primary Sclerosing Cholangitis Cohort Study NCT03146936	Fondazione Epatocentro Ticino	—
Completed	Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function NCT02808312	Gilead Sciences	Phase 1
Recruiting	Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai) NCT06767605	Asociación Española para el Estudio del Hígado	—
Completed	Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) NCT02177136	Intercept Pharmaceuticals	Phase 2
Completed	Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis NCT02061540	Mirum Pharmaceuticals, Inc.	Phase 2
Completed	Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Chol NCT01672853	Gilead Sciences	Phase 2
Completed	Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease NCT01819766	Exact Sciences Corporation	—
Completed	A Pilot Study of Xifaxan to Treat Patients With PSC NCT01695174	Mayo Clinic	Phase 1
Completed	Genomics of Primary Sclerosing Cholangitis (PSC) NCT01161992	Mayo Clinic	—